-
1
-
-
0027281068
-
-
Astrom M, Adolfsson R, Asplund K: Major depression in stroke patients: a 3-year longitudinal study. Stroke 1993; 24:976-982
-
Astrom M, Adolfsson R, Asplund K: Major depression in stroke patients: a 3-year longitudinal study. Stroke 1993; 24:976-982
-
-
-
-
2
-
-
0345451666
-
Frequency and clinical determinants of poststroke depression
-
Pohjasvaara T, Leppavuori A, Siira I, et al: Frequency and clinical determinants of poststroke depression. Stroke 1998; 29:2311-2317
-
(1998)
Stroke
, vol.29
, pp. 2311-2317
-
-
Pohjasvaara, T.1
Leppavuori, A.2
Siira, I.3
-
3
-
-
0025616136
-
Prevalence and course of depressive disorders in hospitalized stroke patients
-
Morris PLP, Robinson RG, Raphael B: Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatr Med 1990; 20:349-364
-
(1990)
Int J Psychiatr Med
, vol.20
, pp. 349-364
-
-
Morris, P.L.P.1
Robinson, R.G.2
Raphael, B.3
-
4
-
-
0037224941
-
Cognitive behavioral psychotherapy for depression following stroke: A randomized controlled trial
-
Lincoln NB, Flannaghan T: Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke 2003; 34:111-115
-
(2003)
Stroke
, vol.34
, pp. 111-115
-
-
Lincoln, N.B.1
Flannaghan, T.2
-
5
-
-
0021346860
-
Nortriptyline treatment of post-stroke depression: A double-blind study
-
Lipsey JR, Robinson RG, Pearlson GD, et al: Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984; 1:297-300
-
(1984)
Lancet
, vol.1
, pp. 297-300
-
-
Lipsey, J.R.1
Robinson, R.G.2
Pearlson, G.D.3
-
6
-
-
0033853342
-
Fluoxetine in early poststroke depression: A double-blind placebo-controlled study
-
Wiart L, Petit H, Joseph PA, et al: Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000; 31:1829-1832
-
(2000)
Stroke
, vol.31
, pp. 1829-1832
-
-
Wiart, L.1
Petit, H.2
Joseph, P.A.3
-
7
-
-
0028232860
-
Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram
-
Andersen G, Vestergaard K, Lauritzen L: Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994; 25:1099-1104
-
(1994)
Stroke
, vol.25
, pp. 1099-1104
-
-
Andersen, G.1
Vestergaard, K.2
Lauritzen, L.3
-
8
-
-
33644875159
-
Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: A double-blind, placebo-controlled study
-
Choi-Kwon S, Han SW, Kwon SU, et al: Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006; 37:156-161
-
(2006)
Stroke
, vol.37
, pp. 156-161
-
-
Choi-Kwon, S.1
Han, S.W.2
Kwon, S.U.3
-
11
-
-
0022450286
-
Electroconvulsive therapy for poststroke depression
-
Murray GB, Shea V, Conn DK: Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 1986; 47:258-260
-
(1986)
J Clin Psychiatry
, vol.47
, pp. 258-260
-
-
Murray, G.B.1
Shea, V.2
Conn, D.K.3
-
12
-
-
1042289314
-
Repetitive transcranial magnetic stimulation as treatment of poststroke depression: A preliminary study
-
Jorge RE, Robinson RG, Tateno A, et al: Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry 2004; 55:398-405
-
(2004)
Biol Psychiatry
, vol.55
, pp. 398-405
-
-
Jorge, R.E.1
Robinson, R.G.2
Tateno, A.3
-
13
-
-
0036238117
-
Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression
-
Kimura M, Kanetani K, Imai R, et al: Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression. Int Clin Psychopharmacol 2002; 17:121-125
-
(2002)
Int Clin Psychopharmacol
, vol.17
, pp. 121-125
-
-
Kimura, M.1
Kanetani, K.2
Imai, R.3
-
14
-
-
0028268739
-
Therapeutic effect of lisuride maleate on post-stroke depression]
-
Japanese
-
Hougaku H, Matsumoto M, Hata R, et al: [Therapeutic effect of lisuride maleate on post-stroke depression]. Nippon Ronen Igakkai Zasshi 1994; 31:52-59 (Japanese)
-
(1994)
Nippon Ronen Igakkai Zasshi
, vol.31
, pp. 52-59
-
-
Hougaku, H.1
Matsumoto, M.2
Hata, R.3
-
15
-
-
0041880679
-
Comprehensive evaluation of canine renal papillary necrosis induced by nefiracetam, a neurotransmission enhancer
-
Tsuchiya Y, Takahashi Y, Jindo T, et al: Comprehensive evaluation of canine renal papillary necrosis induced by nefiracetam, a neurotransmission enhancer. Eur J Pharmacol 2003; 475:119-128
-
(2003)
Eur J Pharmacol
, vol.475
, pp. 119-128
-
-
Tsuchiya, Y.1
Takahashi, Y.2
Jindo, T.3
-
16
-
-
0031914452
-
Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways
-
Nishizaki T, Matsuoka T, Nomura T, et al: Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways. Mol Pharmacol 1998; 53:1-5
-
(1998)
Mol Pharmacol
, vol.53
, pp. 1-5
-
-
Nishizaki, T.1
Matsuoka, T.2
Nomura, T.3
-
17
-
-
27244449904
-
Effects of nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats
-
Kitano Y, Komiyama C, Makino M, et al: Effects of nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats. Epilepsia 2005; 46:1561-1568
-
(2005)
Epilepsia
, vol.46
, pp. 1561-1568
-
-
Kitano, Y.1
Komiyama, C.2
Makino, M.3
-
18
-
-
0141742496
-
Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons
-
Moriguchi S, Marszalec W, Zhao X, et al: Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons. J Pharmacol Exp Ther 2003; 307:160-167
-
(2003)
J Pharmacol Exp Ther
, vol.307
, pp. 160-167
-
-
Moriguchi, S.1
Marszalec, W.2
Zhao, X.3
-
19
-
-
22044437068
-
Mechanisms of action of cognitive enhancers on neuroreceptors
-
Narahashi T, Moriguchi S, Zhao X, et al: Mechanisms of action of cognitive enhancers on neuroreceptors. Biol Pharm Bull 2004; 27:1701-1706
-
(2004)
Biol Pharm Bull
, vol.27
, pp. 1701-1706
-
-
Narahashi, T.1
Moriguchi, S.2
Zhao, X.3
-
20
-
-
0034931481
-
Post-stroke dementia: Nootropic drug modulation of neuronal nicotinic acetylcholine receptors
-
Zhao X, Yeh JZ, Narahashi T: Post-stroke dementia: nootropic drug modulation of neuronal nicotinic acetylcholine receptors. Ann NY Acad Sci 2001; 939:179-186
-
(2001)
Ann NY Acad Sci
, vol.939
, pp. 179-186
-
-
Zhao, X.1
Yeh, J.Z.2
Narahashi, T.3
-
21
-
-
12344271062
-
Effects of nefiracetam on the levels of brain-derived neurotrophic factor and synapsin I mRNA and protein in the hippocampus of microsphere-embolized rats
-
Ando T, Takagi N, Takagi K, et al: Effects of nefiracetam on the levels of brain-derived neurotrophic factor and synapsin I mRNA and protein in the hippocampus of microsphere-embolized rats. Eur J Pharmacol 2005; 507:49-56
-
(2005)
Eur J Pharmacol
, vol.507
, pp. 49-56
-
-
Ando, T.1
Takagi, N.2
Takagi, K.3
-
22
-
-
0036166987
-
Nefiracetam improves the impairment of local cerebral blood flow and glucose utilization after chronic focal cerebral ischemia in rats
-
Jin J, Watabe S, Yamamoto T: Nefiracetam improves the impairment of local cerebral blood flow and glucose utilization after chronic focal cerebral ischemia in rats. Pharmacology 2002; 64:119-125
-
(2002)
Pharmacology
, vol.64
, pp. 119-125
-
-
Jin, J.1
Watabe, S.2
Yamamoto, T.3
-
23
-
-
0013365108
-
Clinical utility of DM-9384 (Nefiracetam) in patients with aftereffect following cerebrovascular disorders: A comparative double-blind study with idebenone]
-
Japanese
-
Otomo E, Kogure K, Hirai S, et al: [Clinical utility of DM-9384 (Nefiracetam) in patients with aftereffect following cerebrovascular disorders: a comparative double-blind study with idebenone]. Rinsho Iyaku (J Clin Ther Med) 1994; 10:1871-1918 (Japanese)
-
(1994)
Rinsho Iyaku (J Clin Ther Med)
, vol.10
, pp. 1871-1918
-
-
Otomo, E.1
Kogure, K.2
Hirai, S.3
-
25
-
-
0014186152
-
Development of a rating scale for primary depressive illness
-
Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
-
(1967)
Br J Soc Clin Psychol
, vol.6
, pp. 278-296
-
-
Hamilton, M.1
-
26
-
-
0020519047
-
A two-year longitudinal study of post-stroke mood disorders: Findings during the initial evaluation
-
Robinson RG, Starr LB, Kubos KL, et al: A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke 1983; 14:736-744
-
(1983)
Stroke
, vol.14
, pp. 736-744
-
-
Robinson, R.G.1
Starr, L.B.2
Kubos, K.L.3
-
29
-
-
0037227914
-
Poststroke depression: An 18-month follow-up
-
Berg A, Psych L, Palomaki H, et al: Poststroke depression: an 18-month follow-up. Stroke 2003; 34:138-143
-
(2003)
Stroke
, vol.34
, pp. 138-143
-
-
Berg, A.1
Psych, L.2
Palomaki, H.3
-
30
-
-
0023194048
-
The Modified Mini-Mental State (3MS) examination
-
Teng EL, Chui HC: The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987; 48:314-318
-
(1987)
J Clin Psychiatry
, vol.48
, pp. 314-318
-
-
Teng, E.L.1
Chui, H.C.2
-
31
-
-
0028970106
-
Folstein vs modified minimental state examination in geriatric stroke: Stability, validity, and screening utility
-
Grace J, Nadler JD, White DA, et al: Folstein vs modified minimental state examination in geriatric stroke: stability, validity, and screening utility. Arch Neurol 1995; 52:477-484
-
(1995)
Arch Neurol
, vol.52
, pp. 477-484
-
-
Grace, J.1
Nadler, J.D.2
White, D.A.3
-
33
-
-
0024328055
-
Measurements of acute cerebral infarction: A clinical examination scale
-
Brott T, Adams HP, Olinger CP, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20:864-870
-
(1989)
Stroke
, vol.20
, pp. 864-870
-
-
Brott, T.1
Adams, H.P.2
Olinger, C.P.3
-
34
-
-
0037811899
-
Does cognitive recovery after treatment of poststroke depression last? A 2-year followup of cognitive function associated with poststroke depression
-
Narushima K, Chan KL, Kosier JT, et al: Does cognitive recovery after treatment of poststroke depression last? A 2-year followup of cognitive function associated with poststroke depression. Am J Psychiatry 2003; 160:1157-1162
-
(2003)
Am J Psychiatry
, vol.160
, pp. 1157-1162
-
-
Narushima, K.1
Chan, K.L.2
Kosier, J.T.3
-
35
-
-
0035148438
-
Improved recovery in activities of daily living associated with remission of post-stroke depression
-
Chemerinski E, Robinson RG, Kosier JT: Improved recovery in activities of daily living associated with remission of post-stroke depression. Stroke 2001; 32:113-117
-
(2001)
Stroke
, vol.32
, pp. 113-117
-
-
Chemerinski, E.1
Robinson, R.G.2
Kosier, J.T.3
-
36
-
-
10044271125
-
Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials
-
Khan A, Brodhead AE, Kolts RI, et al: Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. J Psychiatr Res 2005; 39:145-150
-
(2005)
J Psychiatr Res
, vol.39
, pp. 145-150
-
-
Khan, A.1
Brodhead, A.E.2
Kolts, R.I.3
-
37
-
-
33748551702
-
The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: An extended analysis
-
Lam RW, Andersen HF: The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis. Pharmacopsychiatry 2006; 39:180-184
-
(2006)
Pharmacopsychiatry
, vol.39
, pp. 180-184
-
-
Lam, R.W.1
Andersen, H.F.2
-
38
-
-
0037354080
-
Early fluoxetine treatment of post-stroke depression: A three-month double-blind placebo-controlled study with an open-label long-term follow up
-
Fruehwald S, Gatterbauer E, Rehak P, et al: Early fluoxetine treatment of post-stroke depression: a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 2003; 250:347-351
-
(2003)
J Neurol
, vol.250
, pp. 347-351
-
-
Fruehwald, S.1
Gatterbauer, E.2
Rehak, P.3
-
39
-
-
0034058054
-
Nortriptyline versus fluoxetine in the treatment of depression and in short term recovery after stroke: A placebo controlled, double-blind study
-
Robinson RG, Schultz SK, Castillo C, et al: Nortriptyline versus fluoxetine in the treatment of depression and in short term recovery after stroke: a placebo controlled, double-blind study. Am J Psychiatry 2000; 157:351-359
-
(2000)
Am J Psychiatry
, vol.157
, pp. 351-359
-
-
Robinson, R.G.1
Schultz, S.K.2
Castillo, C.3
-
40
-
-
34250174824
-
Relationship between depression severity entry criteria and antidepressant clinical trial outcomes
-
Khan A, Schwartz K, Kolts RL, et al: Relationship between depression severity entry criteria and antidepressant clinical trial outcomes. Biol Psychiatry 2007; 62:65-71
-
(2007)
Biol Psychiatry
, vol.62
, pp. 65-71
-
-
Khan, A.1
Schwartz, K.2
Kolts, R.L.3
|